[Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray]

Zhen-Ya Hong1, Li-Sha Yi, Xin-Yu Miao

  • 1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science &Technology, Wuhan, Hubei, 430030, P. R. China.

Abstract

Insights

Trichostatin A (TSA) induces apoptosis in Molt-4 cancer cells by down-regulating key genes involved in cell growth and survival. This histone deacetylase inhibitor shows selective toxicity, sparing normal cells.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Context:

  • Histone deacetylase (HDAC) is overexpressed in various cancers, correlating with oncogenic factors.
  • Histone deacetylase inhibitors like trichostatin A (TSA) induce apoptosis in cancer cells, but the mechanism is unclear.
  • Molt-4 cells are a human leukemia cell line often used in cancer research.

Purpose:

  • To investigate the underlying mechanism of trichostatin A (TSA)-induced apoptosis in Molt-4 cells.
  • To characterize global gene expression profiles before and after TSA treatment.
  • To identify specific genes and pathways affected by TSA in cancer cells.

Summary:

  • TSA induces apoptosis in Molt-4 cells in a dose- and time-dependent manner, with minimal toxicity to normal human peripheral blood mononuclear cells (PBMCs).
  • Microarray analysis revealed 313 down-regulated genes after 9 hours of TSA treatment, including those involved in signal transduction, transcription, cell growth, differentiation, and survival.
  • Key genes such as STAT5A, MYC, and ikaros were significantly downregulated, with changes confirmed by RT-PCR and Western blot.

Impact:

  • The findings suggest that TSA's anti-cancer effects stem from down-regulating pro-proliferation and anti-apoptotic genes.
  • This research provides mechanistic insights into TSA's action, potentially guiding the development of novel cancer therapies.
  • Understanding TSA's impact on gene expression can inform targeted therapeutic strategies for hematological malignancies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...